斯洛利木斯用于治疗格雷夫斯轨道病变
Simone Comi1, Elena Sabini1, Giada Cosentino1
1Department of Clinical and Experimental Medicine, Endocrinology Unit I, University of Pisa and University Hospital of Pisa, Via Paradisa 2, Pisa, 56124, Italy.
Thyroid research
|December 2, 2025
概括
西罗利斯 (一种mTOR抑制剂) 在治疗Graves轨道病 (GO) 中表现有前途. 研究表明,它可以减少炎症和纤维化,为这种甲状腺眼睛疾病提供了有效和安全的替代治疗方法.
科学领域:
- 眼科医生 眼科 眼科
- 内分泌学 在内分泌学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 格雷夫斯轨道病 (GO) 是一种影响眼睛的自身免疫性疾病.
- 猛素 (mTOR) 信号通路的哺乳动物点与GO病原发生有关.
- 作为一种mTOR抑制剂的sirolimus已经成为GO的潜在治疗剂.
研究的目的:
- 审查关于mTOR在GO中的作用的现有文献.
- 评估西洛斯在治疗GO患者中的疗效和安全性.
主要方法:
- 使用与Graves的轨道病变和mTOR/sirolimus相关的关键词进行了全面的PubMed搜索.
- 包括的研究是英语原始文章 (临床前和临床).
- 九项研究被选为本次系统性审查.
主要成果:
- 在GO患者中,mTOR信号被上调.
- 在GO模型和患者细胞中,sirolimus治疗减少了炎症媒介,脂肪生成和纤维化.
- 临床病例和回顾性研究表明,西洛是有效的,具有良好的耐受性和血清水平与治疗反应之间的潜在相关性.
结论:
- 西洛利斯为格雷夫斯轨道病症提供了一个潜在的成本效益,安全和有效的治疗选择.
- 血清西洛斯水平可以预测治疗结果.
- 进一步的随机临床试验是必要的,以确认疗效和优化治疗方案.
相关概念视频
Open Angle Glaucoma: Treatment
934
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
934
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
413
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
413
Angle Closure Glaucoma: Treatment
1.1K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
461
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
461
Glaucoma: Overview
1.2K
Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...
1.2K
Myasthenia Gravis: Overview and Treatment
2.7K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.7K


